134 related articles for article (PubMed ID: 36827212)
21. Health Literacy Research Funded by the NIH for Disease Prevention.
Villani J; Trivedi N
Health Lit Res Pract; 2020 Nov; 4(4):e212-e223. PubMed ID: 33170287
[TBL] [Abstract][Full Text] [Related]
22. Primary care for cancer survivors: a review of national institutes of health-funded grants 2017-2022.
Tonorezos E; Mollica M; Tesauro G; Gallicchio L; Guida J; Maher ME; Hudson SV
J Cancer Surviv; 2024 May; ():. PubMed ID: 38819538
[TBL] [Abstract][Full Text] [Related]
23. Disproportionally low funding for trauma research by the National Institutes of Health: A call for a National Institute of Trauma.
Glass NE; Riccardi J; Farber NI; Bonne SL; Livingston DH
J Trauma Acute Care Surg; 2020 Jan; 88(1):25-32. PubMed ID: 31389923
[TBL] [Abstract][Full Text] [Related]
24. Trends in research on energy balance supported by the National Cancer Institute.
Ballard-Barbash R; Siddiqi SM; Berrigan DA; Ross SA; Nebeling LC; Dowling EC
Am J Prev Med; 2013 Apr; 44(4):416-423. PubMed ID: 23498109
[TBL] [Abstract][Full Text] [Related]
25. Gender, Racial, and Ethnic and Inequities in Receipt of Multiple National Institutes of Health Research Project Grants.
Nguyen M; Chaudhry SI; Desai MM; Dzirasa K; Cavazos JE; Boatright D
JAMA Netw Open; 2023 Feb; 6(2):e230855. PubMed ID: 36853608
[TBL] [Abstract][Full Text] [Related]
26. Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.
Lam TK; Chang CQ; Rogers SD; Khoury MJ; Schully SD
Am J Epidemiol; 2015 Apr; 181(7):451-8. PubMed ID: 25767265
[TBL] [Abstract][Full Text] [Related]
27. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.
Tejeda HA; Green SB; Trimble EL; Ford L; High JL; Ungerleider RS; Friedman MA; Brawley OW
J Natl Cancer Inst; 1996 Jun; 88(12):812-6. PubMed ID: 8637047
[TBL] [Abstract][Full Text] [Related]
28. Survivorship science at the National Institutes of Health 2017-2021.
Mollica MA; Tesauro G; Gallicchio L; Guida J; Maher ME; Tonorezos E
J Cancer Surviv; 2023 Jun; ():. PubMed ID: 37301792
[TBL] [Abstract][Full Text] [Related]
29. Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers.
Morgan A; Shah K; Tran K; Chino F
JAMA Netw Open; 2021 Jun; 4(6):e2112807. PubMed ID: 34097046
[TBL] [Abstract][Full Text] [Related]
30. National Heart, Lung, and Blood Institute: Social Determinants of Health Research, Fiscal Year 2008-2020.
Brown AGM; Desvigne-Nickens PM; Redmond N; Barnes VI; Campo RA
Am J Prev Med; 2022 Jul; 63(1):85-92. PubMed ID: 35379518
[TBL] [Abstract][Full Text] [Related]
31. National Cancer Institute funding for rapid cycle interventional research in cancer care delivery.
Norton WE; Neta G; Jacobsen PB
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37862246
[TBL] [Abstract][Full Text] [Related]
32. Healthcare delivery research in older adults with cancer: A review of National Institutes of Health-funded projects.
Sun V; Tuovinen P; Jacobsen PB; Smith AW
J Am Geriatr Soc; 2023 Jul; 71(7):2250-2255. PubMed ID: 36896874
[TBL] [Abstract][Full Text] [Related]
33. Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress?
Fejerman L; Ramirez AG; Nápoles AM; Gomez SL; Stern MC
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):932-941. PubMed ID: 35247883
[TBL] [Abstract][Full Text] [Related]
34. Domain classification and analysis of national institutes of health-funded medical physics research.
Scarpelli M; Whelan B; Farahani K
Med Phys; 2021 Feb; 48(2):605-614. PubMed ID: 32970862
[TBL] [Abstract][Full Text] [Related]
35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
36. Epidemiologic Research of Rare Cancers: Trends, Resources, and Challenges.
Gallicchio L; Daee DL; Rotunno M; Barajas R; Fagan S; Carrick DM; Divi RL; Filipski KK; Freedman AN; Gillanders EM; Lam TK; Martin DN; Rogers S; Verma M; Nelson SA
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1305-1311. PubMed ID: 33795213
[TBL] [Abstract][Full Text] [Related]
37. Do AAO-HNSF CORE Grants Predict Future NIH Funding Success?
Eloy JA; Svider PF; Kanumuri VV; Folbe AJ; Setzen M; Baredes S
Otolaryngol Head Neck Surg; 2014 Aug; 151(2):246-52. PubMed ID: 24847049
[TBL] [Abstract][Full Text] [Related]
38. Using the health belief model to assess racial/ethnic disparities in cancer-related behaviors in an NCI-designated comprehensive cancer center catchment area.
Otto AK; Ketcher D; McCormick R; Davis JL; McIntyre MR; Liao Y; Reblin M; Vadaparampil ST
Cancer Causes Control; 2021 Oct; 32(10):1085-1094. PubMed ID: 34132914
[TBL] [Abstract][Full Text] [Related]
39. Size and characteristics of the biomedical research workforce associated with U.S. National Institutes of Health extramural grants.
Pool LR; Wagner RM; Scott LL; RoyChowdhury D; Berhane R; Wu C; Pearson K; Sutton JA; Schaffer WT
FASEB J; 2016 Mar; 30(3):1023-36. PubMed ID: 26625903
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
